← back to search

Xiaoying Bian

Shandong University · CN
Area of research
Pharmacology · Molecular Biology
Research interest
Research interests include Biology, Heterologous expression, Heterologous, Recombineering, Computational biology, and Genome.
h-index
citations
1,493
works
17
NIH funding
primary concept
email

Recent publications

Feature sequence-based genome mining uncovers the hidden diversity of bacterial siderophore pathways
eLife 2024cited by 15position: middledoi
Microbial chassis engineering drives heterologous production of complex secondary metabolites
Biotechnology Advances 2022cited by 92position: lastdoi
Engineering and elucidation of the lipoinitiation process in nonribosomal peptide biosynthesis
Nature Communications 2021cited by 73position: lastdoi
Rational construction of genome-reduced Burkholderiales chassis facilitates efficient heterologous production of natural products from proteobacteria
Nature Communications 2021cited by 59position: lastdoi
Development of environmentally friendly biological algicide and biochemical analysis of inhibitory effect of diatom Skeletonema costatum
Chinese Chemical Letters 2021cited by 21position: middledoi
Genome Mining, Heterologous Expression, Antibacterial and Antioxidant Activities of Lipoamides and Amicoumacins from Compost-Associated Bacillus subtilis fmb60
Molecules 2021cited by 5position: middledoi
Recombineering for Genetic Engineering of Natural Product Biosynthetic Pathways
Trends in biotechnology 2020cited by 68position: middledoi
Heterologous expression of bacterial natural product biosynthetic pathways
Natural Product Reports 2019cited by 239position: middledoi
Discovery of recombinases enables genome mining of cryptic biosynthetic gene clusters in Burkholderiales species
Proceedings of the National Academy of Sciences 2018cited by 135position: middledoi
Engineering <i>Pseudomonas protegens</i> Pf‐5 to improve its antifungal activity and nitrogen fixation
Microbial Biotechnology 2018cited by 72position: middledoi
Expressing cytotoxic compounds in Escherichia coli Nissle 1917 for tumor-targeting therapy
Research in Microbiology 2018cited by 69position: middledoi
Heterologous Production and Yield Improvement of Epothilones in <i>Burkholderiales</i> Strain DSM 7029
ACS Chemical Biology 2017cited by 51position: firstdoi
RecET direct cloning and Redαβ recombineering of biosynthetic gene clusters, large operons or single genes for heterologous expression
Nature Protocols 2016cited by 185position: middledoi
A new recombineering system for Photorhabdus and Xenorhabdus
Nucleic Acids Research 2014cited by 66position: middledoi
Improved seamless mutagenesis by recombineering using ccdB for counterselection
Nucleic Acids Research 2013cited by 147position: middledoi
In Vivo Evidence for a Prodrug Activation Mechanism during Colibactin Maturation
ChemBioChem 2013cited by 113position: firstdoi
High-Titer Heterologous Production in <i>E. coli</i> of Lyngbyatoxin, a Protein Kinase C Activator from an Uncultured Marine Cyanobacterium
ACS Chemical Biology 2013cited by 83position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Youming Zhang · Shandong University13 papers (2013–2022)Rolf Müller · German Center for Infection Research10 papers (2013–2021)Jun Fu · Shandong University9 papers (2013–2020)A. Francis Stewart · University of Edinburgh5 papers (2013–2018)Aiying Li · Shandong University4 papers (2016–2020)Hailong Wang · Shandong University4 papers (2016–2020)Haibo Zhou · Shandong University3 papers (2018–2021)Jia Yin · Shandong University3 papers (2014–2018)Xue Wang · Shandong University3 papers (2018–2022)Xiaoming Ding · Fudan University3 papers (2017–2021)Hanna Chen · University of Illinois Chicago3 papers (2018–2021)Liujie Huo · Shandong University2 papers (2018–2019)Feng Xu · Huazhong Agricultural University2 papers (2021–2021)Jie Yang · Ministry of Education of the People's Republic of China2 papers (2021–2021)Ruijuan Li · Shandong University2 papers (2018–2018)Lin Zhong · Shandong University2 papers (2021–2021)Qiang Tu · Hunan University of Arts and Science2 papers (2017–2018) · 2 papers (2013–2018) · 2 papers (2013–2014) · 2 papers (2021–2021)